🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#VentureCapital: @ViforPharmaES adquirirá @SanifitLabs, participada por Ysios Capital, Caixa Capital Risc, ALTA LIFE SCIENCES, ColumbusVP, Healthequity y el @CDTIoficial bit.ly/3cz4RnF

Enhorabuena a @SanifitLabs por este broche de oro a estos 17 años de compromiso y esfuerzo. Mérito de Joan Perelló Bestard y todo el equipo, gracias a la apuesta de Caixa Capital Risc Ysios Capital ALTA LIFE SCIENCES @InvivoCapital e #innvierte de @CDTIoficial sanifit.com/vifor-pharma-t…

Very happy to welcome Dr Michel Detheux as Independent Chair to ONA’s board of directors. linkedin.com/posts/ona-ther…

I am thrilled to welcome Dr Michel Detheux as Independent Chair of ONA’s board of directors.

Rumbo a la Fase II PEPTOMYC bit.ly/327Aq6r

#VentureCapital: PEPTOMYC logra 8,6 millones de sus socios y busca más inversores expansion.com/catalunya/2022… a través de expansioncom

Con motivo del día ᴅɪ́ᴀ Iɴᴛᴇʀɴᴀᴄɪᴏ́ɴᴀʟ ᴅᴇ ʟᴀ Eᴅᴜᴄᴀᴄɪᴏ́ɴ, Business Insider entrevista a 61 empresarios, inversores, directivos e investigadores; comentan qué echaron en falta y qué cambiarían de su época en las aulas. bit.ly/3ICgJTX Laura Soucek

Peptomyc is hiring! We are looking for a Clinical distribution and Logistics manager. More info here: bit.ly/3onOh06 If you are interested in this offer please send your CV to [email protected]

"𝑈𝑛 𝑓𝑎̀𝑟𝑚𝑎𝑐 𝑟𝑒𝑣𝑜𝑙𝑢𝑐𝑖𝑜𝑛𝑎𝑟𝑖 𝑞𝑢𝑒 𝑒𝑙𝑖𝑚𝑖𝑛𝑎 𝑐𝑒̀𝑙·𝑙𝑢𝑙𝑒𝑠 𝑐𝑎𝑛𝑐𝑒𝑟𝑜𝑠𝑒𝑠" Laura Soucek, CEO de PEPTOMYC, fue entrevistada ayer en el programa REVOLUCIÓ 4.0 de Catalunya Ràdio cutt.ly/cOKeyA2

MYC inhibition halts metastatic breast cancer progression by blocking tumor growth, invasion & seeding. Congratulations PEPTOMYC Team and Vall d’Hebron Institute of Oncology (VHIO)! Laura Soucek & Daniel Massó-Vallés!

"Parar la proteína 'myc' significa parar el crecimiento de tumores humanos" En el #Canal24Horas han hablado con Laura Soucek, jefa del grupo del Instituto de Oncología Vall d'Hebron (Vall d’Hebron Institute of Oncology (VHIO)) rtve.es/play/videos/la…

#JustPublished! MYC inhibition is anti-metastatic in #BreastCancer by Massó-Vallés, Laura Soucek et al. bit.ly/3tfYP3l PEPTOMYC Vall d’Hebron Institute of Oncology (VHIO) #openaccess

Happy to announce that Oculis Strengthens Leading Ophthalmology Pipeline by InLicensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics altals.com/blog/2022/03/0…

We are pleased to announce that we have signed an exclusive worldwide licensing agreement with Oculis to develop and commercialize a potentially disease modifying therapy to protect and prevent damage to the optic nerve and retina. #glaucoma #opticneuritis accure.health/oculis-strengt…

binx health brings convenient access to high-quality reference laboratory-based testing with the potential to drive better outcomes. Learn more about how we can service your organization or community: mybinxhealth.com/about-us#conta… #COVID19 #STItesting

binx health announced today the appointment of Todd Bennett as CCO. Todd is an accomplished industry veteran, having held multiple executive leadership roles at several high-growth diagnostic and healthcare technology companies. Read more here: bwnews.pr/3COHouI

DeepUll seeks to replace 40-year-old sepsis Dx approach firstwordhealthtech.com/story/5665607 #sepsis #DeepUll #moleculardiagnostics #healthtech #advancedIVD #AI #innovation

Los fondos obtenidos por la 'start up' fundada en 2020 por Jordi Carrera y Rafel Bru se utilizarán para avanzar en el desarrollo de su plataforma de reconocimiento de la sepsis. Tino Fernández Expansión Start Up expansion.com/expansion-empl…

#PCBCommunity | #DeepUll, based in #PCB_UB, raises €13M Series B financing to progress its first-in-class early #sepsis recognition platform towards the market @CDTI_innovacion Ministerio de Ciencia, Innovación y Universidades ICO ALTA LIFE SCIENCES KurmaPartners UI Investissement #MedicalDiagnostics pcb.ub.edu/en/deepull-rai…

DeepUll consigue 13 millones para avanzar en el diagnóstico de la sepsis dozz.es/mah0q2